Belviq's Sales Will Disappoint: Demog...

Belviq's Sales Will Disappoint: Demographics Matter

There are 1 comment on the Seeking Alpha story from May 10, 2013, titled Belviq's Sales Will Disappoint: Demographics Matter. In it, Seeking Alpha reports that:

Arena Pharmaceuticals has now received its long anticipated scheduling for Belviq from the DEA , and its fate in Europe , at least in the short-term, is a known for investors.

Join the discussion below, or Read more at Seeking Alpha.

Brian

Boca Raton, FL

#1 Jun 8, 2013
This is terrible news as I am a CNPR (Certified National Pharmaceutical representative, and I am always looking for new drugs to sell. If you want information on pharmaceutical sales look up my blog http://www.brianbrowncnpr.com

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Merck's shingles vaccine, Zostavax, recommended... (Jun '08) 15 hr StevenB 76
News Obama asks Congress for $1.8 billion to fight Zika Fri Science and Math 13
News Premature Ejaculation Drug (Jul '06) Jan 31 Dr Wu 33
News Drugmaker Pfizer sees profit gain after acquisi... (May '10) Jan 31 Noell 18
News Vivus Wins FDA Approval (Aug '12) Jan 31 Tara 13
News Earnings Preview: Pfizer to report 2Q earnings (Aug '10) Jan 31 Sharolyn 18
News Q1 2016 EPS Estimates for McKesson Co. (MCK) De... Jan 30 Syntax Error 1
More from around the web